D
David O. Meltzer
Researcher at University of Chicago
Publications - 379
Citations - 21238
David O. Meltzer is an academic researcher from University of Chicago. The author has contributed to research in topics: Health care & Population. The author has an hindex of 68, co-authored 367 publications receiving 18131 citations. Previous affiliations of David O. Meltzer include MacLean Center for Clinical Medical Ethics & University of Arkansas for Medical Sciences.
Papers
More filters
Journal ArticleDOI
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D Sanders,Peter J. Neumann,Anirban Basu,Dan W. Brock,David Feeny,Murray Krahn,Karen M. Kuntz,David O. Meltzer,Douglas K Owens,Lisa A. Prosser,Joshua A. Salomon,Mark Sculpher,Thomas A Trikalinos,Louise B. Russell,Joanna E. Siegel,Theodore G. Ganiats +15 more
TL;DR: The Second Panel on Cost-Effectiveness in Health and Medicine reviewed the current status of the field of cost-effectiveness analysis and developed a new set of recommendations, including the recommendation to perform analyses from 2 reference case perspectives and to provide an impact inventory to clarify included consequences.
Journal ArticleDOI
Delivering affordable cancer care in high-income countries
Richard Sullivan,Jeffrey Peppercorn,Karol Sikora,John Zalcberg,Neal J. Meropol,Eitan Amir,David Khayat,Peter Boyle,Philippe Autier,Ian F. Tannock,Tito Fojo,Jim Siderov,Steve Williamson,Silvia Camporesi,J. Gordon McVie,Arnie Purushotham,Peter Naredi,Alexander M.M. Eggermont,Murray F. Brennan,Michael L. Steinberg,Mark De Ridder,Susan A. McCloskey,Dirk Verellen,Terence Roberts,Guy Storme,Rodney J. Hicks,Peter J. Ell,Bradford R. Hirsch,David P. Carbone,Kevin A. Schulman,Paul Catchpole,David Taylor,Jan Geissler,Nancy G Brinker,David O. Meltzer,David J. Kerr,Matti Aapro +36 more
TL;DR: Urgent solutions range from re-engineering of the macroeconomic basis of cancer costs (eg, value-based approaches to bend the cost curve and allow cost-saving technologies), greater education of policy makers, and an informed and transparent regulatory system.
Journal ArticleDOI
Communication failures in patient sign-out and suggestions for improvement: a critical incident analysis
Vineet M. Arora,Julie K. Johnson,Julie K. Johnson,David M. Lovinger,Holly J. Humphrey,David O. Meltzer +5 more
TL;DR: Omitted content or failure-prone communication processes (such as lack of face-to-face discussion) emerged as major categories of failed communication that led to uncertainty during decisions on patient care.
Journal ArticleDOI
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
TL;DR: It is very unlikely that $50,000 per Quality-Adjusted Life-Year (QALY) is consistent with societal preferences in the United States.
Journal ArticleDOI
Accounting for future costs in medical cost-effectiveness analysis.
TL;DR: In this article, the authors show that cost-effectiveness analysis is consistent with lifetime utility maximization only if it includes all future medical and non-medical expenditures, and that the magnitude of these future costs suggest that they may substantially alter both the absolute and relative cost effectiveness of medical interventions.